New study results show among patients undergoing percutaneous coronary intervention (PCI) with stents, the risk…
Month: September 2013
Treatment with the anti-diabetic drug alogliptin does not increase CV risk in patients with ACS
Patients with Type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes…
Health of older women in developed countries continues to improve: Gap with developing countries grows
Measures taken in developed countries to reduce noncommunicable diseases — the leading causes of death…
TAVI feasible in bicuspid aortic valve, study suggests
Transcatheter aortic valve implantation (TAVI) is feasible in patients with bicuspid aortic valve, according to…
ASSURE study of experimental agent to raise HDL yields ‘disappointing and surprising’ results
The search continues for an agent that increases high-density lipoprotein and reduces arterial plaque, after…
Scientists sequence genome of high-value grape, seek secrets of wine’s aroma
Demystifying the chemical processes that create a wine’s aroma, and the invaluable potential application of…
Metabolically healthy women have same CVD risk regardless of BMI
A Danish study followed 261,489 women with no prior history of cardiovascular disease for an…
Women less likely to die after TAVI than men
Women are 25 percent less likely to die one year after TAVI than men, according…
Pacemaker for slow heart rhythm restores life expectancy, study suggests
The FollowPace study provides detailed documentation of current standard pacemaker care in a large representative…
TAVI is safe alternative to redo cardiac surgery, study suggests
TAVI is a safe alternative to redo cardiac surgery for failing bioprosthetic valves, according to…